TheraRadar
← Back
Data updated: Mar 29, 2026

ANDA REPOSITORY

Infectious DiseaseRespiratoryDermatology
Generics

ANDA REPOSITORY is a generic drug manufacturer focused on Infectious Disease, Respiratory, Dermatology.

1992
Since
21
Drugs
-
Trials
314
Approved (2yr)

Key Drugs

FLAC
fluocinolone acetonide
1 indications · 2018
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
diatrizoate meglumine
1 indications · 2022

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
METHAZOLAMIDE 2026-02-09
PREGABALIN 2026-02-03
Labeling
PREGABALIN 2026-02-02
Labeling
PREGABALIN 2026-02-02
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 40%
4 drugs
Respiratory 20%
2 drugs
Dermatology 20%
2 drugs
Cardiovascular 10%
1 drugs
Neurology 10%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

LEDERLE big-pharma
Infectious Disease, Cardiovascular, Neurology, Dermatology, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Respiratory
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Respiratory
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
PAI HOLDINGS PHARM big-pharma
Dermatology, Infectious Disease, Neurology, Cardiovascular